What is the current valuation of the India nanomedicine market in 2024?

The overall market valuation was $13.69 Billion in 2024. Read More

What is the projected market size for the India nanomedicine market by 2035?

The projected valuation for 2035 is $49.92 Billion. Read More

What is the expected CAGR for the India nanomedicine market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 12.48%. Read More

Which application segment is expected to have the highest growth in the India nanomedicine market?

The Drug Delivery application segment is projected to grow from $4.1 Billion to $15.1 Billion. Read More

What are the key types of nanomedicine products in the market?

Key types include Nanoparticles, Nanoshells, Nanorobots, and Nanocapsules, with Nanoparticles expected to grow from $4.5 Billion to $16.5 Billion. Read More

Which end-use segment shows promising growth in the India nanomedicine market?

The Pharmaceuticals end-use segment is anticipated to expand from $4.1 Billion to $15.1 Billion. Read More

What technology segment is projected to experience significant growth in the India nanomedicine market?

Targeted Drug Delivery technology is expected to grow from $4.1 Billion to $15.1 Billion. Read More

Who are the leading players in the India nanomedicine market?

Key players include Amgen Inc, Bristol-Myers Squibb Company, Johnson & Johnson, and Roche Holding AG. Read More

What is the growth outlook for the Diagnostic Imaging application in the India nanomedicine market?

The Diagnostic Imaging application is projected to grow from $3.2 Billion to $10.5 Billion. Read More

How does the growth of the Regenerative Medicine application compare to other segments?

Regenerative Medicine is expected to grow from $2.9 Billion to $12.3 Billion, indicating robust potential. Read More

India Nanomedicine Market

ID: MRFR/HC/51710-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

India Nanomedicine Market Research Report By Application (Drug Delivery, Diagnostic Imaging, Therapeutic Applications, Regenerative Medicine), By Type (Nanoparticles, Nanoshells, Nanorobots, Nanocapsules), By End Use (Pharmaceuticals, Biotechnology, Healthcare, Research Laboratories) and By Technology (Targeted Drug Delivery, Nanocarriers, Nanotherapeutics, Nanodiagnostics) -Forecast to 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Chemicals and Materials, BY Application (USD Billion)
4.1.1 Drug Delivery
4.1.2 Diagnostic Imaging
4.1.3 Therapeutic Applications
4.1.4 Regenerative Medicine
4.2 Chemicals and Materials, BY Type (USD Billion)
4.2.1 Nanoparticles
4.2.2 Nanoshells
4.2.3 Nanorobots
4.2.4 Nanocapsules
4.3 Chemicals and Materials, BY End-use (USD Billion)
4.3.1 Pharmaceuticals
4.3.2 Biotechnology
4.3.3 Healthcare
4.3.4 Research Laboratories
4.4 Chemicals and Materials, BY Technology (USD Billion)
4.4.1 Targeted Drug Delivery
4.4.2 Nanocarriers
4.4.3 Nanotherapeutics
4.4.4 Nanodiagnostics
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Chemicals and Materials
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Amgen Inc (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Bristol-Myers Squibb Company (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Johnson & Johnson (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Roche Holding AG (CH)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Novartis AG (CH)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Pfizer Inc (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Merck & Co Inc (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Gilead Sciences Inc (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 INDIA MARKET ANALYSIS BY APPLICATION
6.3 INDIA MARKET ANALYSIS BY TYPE
6.4 INDIA MARKET ANALYSIS BY END-USE
6.5 INDIA MARKET ANALYSIS BY TECHNOLOGY
6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6.7 RESEARCH PROCESS OF MRFR
6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.14 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
6.15 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Billion)
6.16 CHEMICALS AND MATERIALS, BY END-USE, 2024 (% SHARE)
6.17 CHEMICALS AND MATERIALS, BY END-USE, 2024 TO 2035 (USD Billion)
6.18 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
6.19 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 India MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
7.2.2 BY TYPE, 2025-2035 (USD Billion)
7.2.3 BY END-USE, 2025-2035 (USD Billion)
7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Billion, 2025-2035)

Drug Delivery
Diagnostic Imaging
Therapeutic Applications
Regenerative Medicine

Chemicals and Materials By Type (USD Billion, 2025-2035)

Nanoparticles
Nanoshells
Nanorobots
Nanocapsules

Chemicals and Materials By End-use (USD Billion, 2025-2035)

Pharmaceuticals
Biotechnology
Healthcare
Research Laboratories

Chemicals and Materials By Technology (USD Billion, 2025-2035)

Targeted Drug Delivery
Nanocarriers
Nanotherapeutics
Nanodiagnostics

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓